Microbio Co., Ltd. (TPEX:4128)

Market Cap	19.35B
Revenue (ttm)	1.68B
Net Income (ttm)	-873.89M
Shares Out	588.17M
EPS (ttm)	-1.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,065,795
Average Volume	1,222,331
Open	33.10
Previous Close	33.05
Day's Range	32.90 - 33.75
52-Week Range	29.50 - 46.62
Beta	1.45
RSI	51.45
Earnings Date	Mar 7, 2025

About Microbio

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is base...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2000
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4128